StockNews.com Downgrades Select Medical (NYSE:SEM) to Hold

Select Medical (NYSE:SEM) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday.

Other research analysts have also issued research reports about the company. Bank of America started coverage on Select Medical in a report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price target on the stock. Royal Bank of Canada increased their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, Benchmark restated a “buy” rating and set a $48.00 price target on shares of Select Medical in a research note on Friday, November 1st. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $40.75.

Select Medical Stock Performance

Shares of SEM stock opened at $38.09 on Thursday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 52 week low of $22.26 and a 52 week high of $40.98. The firm has a 50 day moving average of $34.93 and a 200-day moving average of $34.92. The company has a market cap of $4.93 billion, a price-to-earnings ratio of 17.80, a price-to-earnings-growth ratio of 1.95 and a beta of 1.42.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business’s revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.46 earnings per share. On average, equities analysts forecast that Select Medical will post 2.16 earnings per share for the current year.

Institutional Investors Weigh In On Select Medical

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC grew its stake in shares of Select Medical by 16.6% in the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after acquiring an additional 330 shares in the last quarter. Foster & Motley Inc. grew its position in Select Medical by 3.1% in the 2nd quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock worth $426,000 after purchasing an additional 370 shares in the last quarter. KBC Group NV increased its stake in Select Medical by 4.5% in the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock valued at $455,000 after buying an additional 563 shares during the last quarter. Arizona State Retirement System lifted its position in shares of Select Medical by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock worth $1,071,000 after buying an additional 593 shares in the last quarter. Finally, Hexagon Capital Partners LLC boosted its stake in shares of Select Medical by 528.7% in the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after buying an additional 645 shares during the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.